Article Text

Reminder of important clinical lesson
Anticonvulsant hypersensitivity syndrome closely mimicking Kawasaki disease
  1. Elpis Mantadakis1,
  2. Aggelos Tsalkidis1,
  3. Emmanouel Paraskakis1,
  4. Kyriaki Papadopoulou-Legbelou2,
  5. George Varlamis2,
  6. Athanassios Evangeliou2,
  7. Athanassios Chatzimichael1
  1. 1
    Democritus University of Thrace, Department of Pediatrics, 6th Kilometer Alexandroupolis-Makris, 68100 Alexandroupolis, Thrace, Greece
  2. 2
    University of Thessaloniki, 4th Department of Pediatrics, Papageorgiou General Regional Hospital of Thessaloniki, 56429 Thessaloniki, Greece
  1. Elpis Mantadakis, emantada{at}med.duth.gr

Summary

Anticonvulsant hypersensitivity syndrome (AHS) is an acute, life-threatening, idiosyncratic drug reaction seen within 1–8 weeks after administration of an aromatic antiepileptic drug. The authors present the case of a 16-month-old boy who developed prolonged fever, a generalised pruritic rash and eosinophilia within 4 weeks after starting treatment with phenobarbital for complicated febrile seizures. He gradually fulfilled the diagnostic criteria for classical Kawasaki disease (KD), although the rash and the subsequent desquamation were atypical, he did not defervesce quickly with administration of corticosteroids and intravenous γ-globulin, and he had only two suggestive cardiac features of KD—that is, perivascular echogenicity of the coronary arteries and a small pericardial effusion. Other conditions considered in the differential diagnosis were excluded by appropriate extensive serological and microbiological studies. He recovered fully. This report shows that drugs such as phenobarbital may be responsible for febrile exanthematous illnesses that closely mimic KD.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests: none.

  • Patient consent: Patient/guardian consent was obtained for publication.